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1. Introduction 
BrAcPhe-tRNA [l-4] and other reactive peptidyl- 
tRNA analogues (5-8) have been used to identify 50 S 
proteins located in or near the donor and acceptor 
sites of the peptidyl transferase center of the 50 SE. 
coli ribosome. Many antibiotic inhibitors of peptidyl 
transferase have been shown to interfere with the 
ribosome binding of the 3’-end of peptidyl- or amino- 
acyl-tRNA [9-l 11. We have examined the effect of 
some of these antibiotics on the pattern of reaction 
of BrAcPhe-tRNA with 50 S proteins. This provides 
more detailed information about the mechanism of 
these antibiotics than is available from simple binding 
measurements. In the absence of antibiotics, P site- 
bound BrAcPhe-tRNA reacts chiefly with the 50s 
proteins L2 and L26-27 [2,3]. The peptidyl trans- 
ferase inhibitors chloramphenicol, sparsomycin, lin- 
comycin, celesticetin, and streptogramin A preferen- 
tially inhibit reaction with L2. Sparsomycin and 
streptogramin A actually enhance the reaction with 
L26-27. Streptomycin and tetracycline, two antibiotics 
which are not considered peptidyl transferase inhibi- 
tors, do not show differential effects on the reaction 
with L2 and L26-27. 
2. Materials and methods 
2.1. Materials 
E coZi ribosomes and BrAc [ 3 H] Phe-tRNA were 
prepared as described elsewhere [ 1,3] . Streptomycin 
and chloramphenicol were obtained from Sigma Che- 
mical Co. Lincomycin and celesticetin were the 
generous gift of the Upjohn Co., Kalamazoo, Mich. 
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Sparsomycin was the gift of Drug Research and De- 
velopment, Chemotherapy, National Cancer Institute. 
Streptogramin A was purified from crude strepto- 
gramin (gift of Merck, Sharpe and Dohme, Rahway, 
New Jersey) by fractional crystallization from ethyl 
acetate [ 121 . 
2.2. Ribosome labeling reactions 
Ribosome labeling reaction mixtures contained 
400 ‘4 260 units of ribosomes, 20 A 260 units of poly 
U and 1 .l /Xi BrAc[j H] Phe-tRNA iri 2 ml buffer A 
(0.01 M Tris-HCl, pH 7.5,0.02 M NH4Cl, 0.01 M 
MgCl2). Where indicated, antibiotics were added to 
the ribosomes prior to the addition of BrAcPhe-tRNA. 
The reaction mixtures were incubated at 37°C for 
30 min. Following this incubation the labeled ribo- 
somes were dissociated into subunits and the 50 S pro- 
teins were isolated and analyzed by gel electrophoresis 
as described elsewhere [3] . 
2.3. Assays 
Binding of BrAc [ 3 H] Phe-tRNA to ribosomes was 
determined according to the method of Nirenberg and 
Leder [13] using aliquots from the labeling reaction 
mixtures containng 2 AZ60 units of ribosomes. 
Puromycin reaction was determined by a modification 
of the method of Leder and Burtzyn [ 141.0.05 ml 
aliquots were taken from the labeling reaction mix- 
ture and made 4 mM in puromycin. The samples were 
then incubated for 5 min at 37°C and the reaction 
was stopped by dilution with 1 .O ml cold buffer A. 
3.0 ml ethyl acetate were then added. After vigorous 
shaking, 1 l/2 ml of the ethyl acetate layer was with- 
drawn and the ‘H determined in a dioxane-based 
scintillation cocktail. 
North-Holland Publishing Company - Amsterdam 
Volume 45, number 1 FEBS LETTERS September 1974 
3. Results 
3.1. Binding of BrAcPhe- tRNA to ribosomes 
Total binding of BrAc13 II] Phe-tRNA to 70 S ribo- 
somes was measured after incubation under condi- 
tions where the binding has been shown to be mostly 
to the P site [3,4] . As shown in table 1, the effect of 
five peptidyl transferase inhibitors is very small. Spar- 
somycin produces a slight stimulation of the binding 
and streptogramin A an even smaller one. Chloramphe- 
micol, lincomycin and celesticetin inhibit the binding 
by very small, but reproducible amounts. Two other 
antibiotics, streptomycin and tetracycline produce a 
larger inhibition of the binding than any of the pepti- 
dyl transferase inhibitors studied here. Both of these 
antibiotics are thought to act chiefly on the 30 S subu- 
nit [15]. 
3.2. firomycin reaction of BrAcPhe-tRNA 
In contrast to their small effect on total binding, 
the five peptidyl transferase inhibitors produced a 
marked inhibition of the reaction of BrAcPhe-tRNA 
with puromycin. The puromycin reaction was measured 
under the same conditions used to measure the bind- 
ing, by following the formation of BrAcPhe-puromycin. 
These results are also shown in table 1. In the presence 
of chloramphenicol, sparsomycin and streptogramin 
A, the inhibition of the puromycin reaction was 
nearly complete. Lincomycin and celesticetin were less 
effective inhibitors of this reaction, giving 68% and 
60% inhibition respectively. They gave somewhat 
better inhibition, however, if the 37°C incubation of 
the samples prior to addition of the puromycin was 
omitted (see table 1). Perhaps these two antibiotics 
can be competed away from the puromycin-reactive 
site by the CCA end of BrAcPhe-tRNA during the 30 
min incubation. 
Tetracycline and streptomycin show very little 
inhibition of the puromycin reaction. This is consis- 
tent with the results of other authors [ 16-181 and 
with the notion that they act chiefly on the 30s 
subunit. The small inhibition of the puromycin reac- 
tion that is seen in their presence is similar to the 
amount of inhibition of the binding of BrAcPhe-tRNA. 
3.3. Covalent reaction of BrAcPhe-tRNA with the ri- 
bosome 
The effect of peptidyl transferase inhibitors on the 
covalent reaction of BrAcPhe-tRNA with SOS proteins 
is shown in fig. 1. This figure shows the results of one- 
Table 1 
Binding to 70s ribosomes and puromycin reaction of 
BrAc[sH]Phe-tRNA in the presence of antibiotics 
After 37°C 30 min incubation 
Additions. 
None 
1 mM Chloramphenicol 
1 mM Lincomycin 
1 mM Celesticetin 
0.1 mM Sparsomyein 
0.1 mM Streptogramin A 
0.1 mM Streptomycin 
0.5 mM Tetracycline 
Binding Puromycin reaction 
100% 100% 
98% 4% 
98% 32% 
98% 40% 
110% 4% 
107% 2% 
76% 73% 
87% 82% 
No preincubation 
None 100% 
1 mM Lincomycin 11% 
1 mM Celesticetin 32% 
BrAcPhetRNA labeling reactions were performed with antibiotics added 
at the indicated concentrations prior to the addition of BrAcPhe-tRNA. 
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Fig. 1. Effect of Peptidyl Transferase Inhibitors on the 50 S 
Labeling Pattern of BrAcPhe-tRNA. Labeling reactions and 
one-dimensional gel analysis of labeled 50 S proteins were 
performed as described in Materials and methods. Where 
indicated, antibiotics were added to the labeling mixtures 
prior to the addition of BrAcPhe-tRNA at the following to 
the concentrations; 1 mM chlorampheriicol; 1 mM lincomycin; 
1 mM celesticetin; 0.1 mM sparsomycin; 0.1 mM streptogramin 
A. The amounts of protein applied to each gel were: a) 0.50 
mg b) 0.41 mg c) 0.48 mg d) 0.53 mg e) 0.53 mg f10.48 mg. 
dimensional acrylamide gel analysis of 50 S proteins 
isolated from 70 S ribosomes which have been in- 
cubated with B~Ac[~ H] Phe-tRNA. These are two 
main peaks of radioactivity corresponding to proteins 
L2 and L26-2?. The identification of these two pro- 
teins has been confirmed by two-dimensional gel 
analysis for the control [2,3] and the lincomycin and 
sparsomycin containing samples [ 12 ] . In the absence 
of antibiotics, the relative extent to which these pro- 
teins react with BrAcPhe-tRNA is somewhat variable 
depending on the preparation of ribosomes used. -en 
parallel labeling reactions are done with ribosomes 
from the same antibiotic-free preparation, however, 
the ratio of labeling of the two proteins is constant 
[4] . Thus all BrAcPhe-tRNA labeling reactions in the 
presence of antibiotics were performed in parallel 
with a control sample. All five peptidyl transferase 
inhibitors dramatically supress the reaction of BrAc 
Phe-tRNA with L2. No new 50s proteins are labeled. 
The peaks of radioactivity always correspond to the 
positions on the gel of L2 and L26-27 as determined 
by comparison with the control gel. Table 2 shows 
quantitative results from two different experiments. 
The [3 H] Phe incorporated into L2 and L26-27 was 
determined as the area under the peaks in the one-di- 
mensional gel analysis normalized by the amount of 
total SOS protein actually applied to each gel. Chlo- 
ramphenicol inhibits the labeling of L2 to the greatest 
extent, but all the antibiotics tested inhibit this 
labeling by at least 73% in experiment 1 and 48% in 
experiment 2. Chloramphenicol, lincomycin, and celes- 
ticetin also inhibit the labeling of L26-27, but to a 
lesser extent than that of L2. Sparsomycin and strep- 
togramin A, on the other hand, stimulate the labeling 
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Fig. 2. Effect of Streptomycin on the 50 S Labeling Pattern 
of BrAcPhe-tRNA. Labeling reaction and one-dimensional 
gel analysis of labeled 50s proteins were performed as de- 
scribed in Materials and methods. Where indicated 0.1 mM 
streptomycin was added to the labeling mixture prior to the 
addition of BrAcPhe-tRNA. The amounts of proteins applied 
to the gels were: a) 0.42 mg and b) 0.52 mg. 
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Table 2 
Covalent labeling of proteins L2 and L26-27 by 
BrAc[ 3H]Phe-tRNA in the presence of antibiotics 
cpm/ .5 mg TP50 
Experiment 1 Experiment 2 
L2 L27 L2 L27 
- - - - 
None 246 240 123 282 
1 mM Chloramphenicol 15 183 34 123 
1 mM Lincomycin 63 194 64 182 
1 mM Celesticetin 32 109 - - 
0.1 mM Sparsomycin 67 305 61 358 
1 mM Streptogramin A 35 363 59 306 
70 S ribosomes were labeled in BrAcPhe-tRNA labeling reactions in the 
presence of antibiotics as indicated. The 50 S proteins were then isolated 
and analyzed by one-dimensional gel electrophoresis. All the values were 
then normalized to account for the amount of protein applied to the gels. 
of L26-27. Thus the effect of all the peptidyl trans- 
ferase inhibitors studied, apart from any effect on the 
total amount of covalent labeling, is to change the 
ratio of labeling of L2 and L26-27 to favor labeling 
of L26-27. 
In contrast, streptomycin inhibits the total cova- 
lent labeling of BrAcPhe-tRNA somewhat but does 
not change the ratio of labeling of L2 and L26-27. 
This is shown in fig. 2. The amount of inhibition of 
covalent labeling is roughly the same as the inhibition 
of the binding of BrAcPhe-tRNA by streptomycin. 
Tetracycline shows equivalent effects [3] . Therefore 
the preferential inhibition of L2 labeling shown by 
all the antibiotics listed in table 2 seems related to 
their ability to inhibit the puromycin reaction. There 
is no quantitative correlation between the ability of 
an antibiotic to inhibit the puromycin reaction and 
its inhibition of L2 labeling. This may indicate that 
these antibiotics inhibit peptide bond formation by 
somewhat different mechanisms. 
4. Discussion 
Peptidyl transferase inhibitors produce a dramatic 
decrease in the covalent labeling of L2 with only a 
small effect on the total binding of BrAcPhe-tRNA. 
They appear to interfere specifically with the binding 
of the CCA end of the affinity label without disrupting 
other ribosome-tRNA interactions. The inhibition of 
covalent labeling by streptomycin and tetracycline is 
probably simply the result of their inhibition of affini- 
ty label binding. 
Peptidyl transferase inhibitors could alter the cova- 
lent BrAcPhe-tRNA reaction by direct steric blocking, 
or by induced conformational changes. Most evidence 
indicates that chloramphenicol binds to the A site of 
the peptidyl transferase center [ IO,1 1 ] . The results 
presented here, however, indicate that chlorampheni- 
co1 severely distorts the interaction of peptidyl-tRNA 
with the P site. This could result from a conformation 
change in the ribosome produced by A site-bound 
chloramphenicol. However, direct steric effects are 
also possible since it has been reported [ 1 l] that there 
are two chloramphenicol binding sites on the ribosome. 
Sparsomycin stimulates the enzymatic binding of 
AcPhe-tRNA approximately 3-fold [ 191. Monro et 
al. [20] observed a sparsomycin-induced stimulation 
of CACCA-Leu-AC binding to 50 S subunits. These 
results were interpreted in terms of a very stable, inert 
complex between the CCA end of peptidyl-tRNA and 
the 50 S subunit in the presence of this antiobiotic. 
Our results show that sparsomycin inhibits the labeling 
of L2 while stimulating that of L26-27. This suggests 
that in the sparsomycin-ribosome-BrAcPhe-tRNA com- 
plex the CCA end of BrAcPhe-tRNA is shifted toward 
the reactive group of L26-27 and away from that of 
L2. It implies that L26-27 is further from the puro- 
mycin-reactive binding site than L2. This is consistent 
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with results reported elsewhere [21] obtained with 
longer peptidyl-tRNA affinity analogues. 
Celma et al. have reported that chloramphenicol 
and celesticetin slightly stimulate the binding of 
CACCA-Leu-AC [9] _ Lincomycin which is structu- 
rally similar to celesticetin inhibits the fragment bind- 
ing by 64% [9] . All these antibiotics inhibit the cova- 
lent reaction of BrAcPhe-tRNA with both L2 and 
L26-27. Streptogramin A which inhibits the binding 
of CACCA-Leu-Ac very effectively [9] (by 92%) inhi- 
bits the labeling of L2 but not of L26-27. Sparsomycir, 
stimulates the binding of CACCA-Leu-AC [9] and 
also stimulates the reaction of L26-27, but inhibits 
the labeling of L2. 
It is not certain that the binding is the same under 
our conditions and those of Celma et al. which in- 
cluded 50% ethanol [9]. If it is the same, our results 
indicate that chloramphenicol, lincomycin and celesti- 
cetin are not simply preventing the binding of the 
3’ end of BrAcPhe-tRNA. Rather they are perturbing 
the ribosome-tRNA interaction in such a way as to 
make the reactive groups of L2 and L26-27 less avail- 
able for reaction. In contrast, sparsomycin and strepto- 
gramin A are producing a pertubation which makes 
L26-27 more available and L2 less available for reac- 
tion with the affinity label. Thus the notion that many 
of the peptidyl transferase inhibitors act by competing 
for substrate binding at the donor or acceptor site of 
peptidyl transferase may be an oversimplified view. 
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